ELBIT SYSTEMS LTD annual report, Q4 FY2023

Elbit Systems Ltd. — FY2023 Form 20-F Summary

Reporting period: Fiscal year ended December 31, 2023. Although the request metadata says “2023 Q4,” this filing is an annual report and does not provide a clear standalone fourth-quarter income statement or cash-flow summary. Financial statements are prepared under U.S. GAAP and presented in U.S. dollars.

Business context

Elbit develops and supplies defense, homeland-security and commercial-aviation systems and services. Its five reportable segments are Aerospace, C4I and Cyber, ISTAR and EW, Land, and Elbit Systems of America (ESA). Sales are predominantly to governments and prime contractors; the Israeli Ministry of Defense (IMOD) and U.S. government represented 16% and 17% of FY2023 revenue, respectively.

Key financial results

Metric	FY2023	FY2022	Change
Revenue	$5,974.7 million	$5,511.5 million	Up 8.4%
Gross profit / margin	$1,483.0 million / 24.8%	$1,373.3 million / 24.9%	Margin down 0.1 percentage point
Operating income / margin	$369.1 million / 6.2%	$367.5 million / 6.7%	Income nearly flat; margin down 0.5 point
Net income attributable to shareholders	$215.1 million	$275.4 million	Down 21.9%
Diluted EPS	$4.82	$6.18	Down 22.0%
Operating cash flow	$113.7 million	$240.1 million	Down $126.4 million

• Net financial expenses rose to $137.8 million from $51.4 million, mainly due to higher interest rates. The effective tax rate was 10.1%, versus 8.2%; both years’ tax expense included benefits from prior-year tax settlements.
• Operating cash flow was pressured by a $351.6 million increase in inventories and a $96.6 million cash use from receivables and contract assets, partly offset by higher payables and non-cash items. Capital spending on property, plant and equipment was $187.0 million; operating cash flow less this spending was approximately negative $73 million.
• At year-end, cash and cash equivalents were $197.4 million and short-term bank deposits were $10.5 million. Working capital was $684 million and the current ratio was 1.14.
• Year-end borrowings were approximately $1.04 billion, comprising short-term credit, loans and commercial paper, current maturities, long-term loans and Series B, C and D Notes. Commercial paper of about $314 million bears three-month SOFR plus 1%; the company reported material compliance with its debt covenants.
• Backlog reached $17.756 billion, up from $15.118 billion; 72% was for orders outside Israel. Approximately 60% was scheduled for performance in 2024–2025. Backlog is not a guarantee of future sales.

Material changes versus FY2022

• Revenue growth was broad-based: Aerospace rose 8%, C4I and Cyber 6%, ISTAR and EW 13%, and Land 12%; ESA revenue was broadly unchanged. Europe’s share of revenue increased to 29.7% from 22.6%, while North America’s declined to 23.7% from 27.0%.
• Segment operating income improved notably in ISTAR and EW ($134.9 million versus $49.1 million) and Land ($80.6 million versus $28.6 million), reflecting revenue growth, program mix and, for Land, progress in IMI’s operational transformation. ESA recorded a $4.7 million operating loss, compared with $75.0 million operating income in 2022.
• Profitability was affected by $18 million of inventory write-offs associated with closing an underperforming subsidiary and a $34 million write-off of uncollectible contract assets on a discontinued project. Management said these items reduced FY2023 diluted EPS by approximately $0.90, net of tax.
• Management reported unfavorable cumulative catch-up adjustments to estimates at completion on significant contracts: $51 million in cost of revenues and $44.7 million in net income, or $1.00 per diluted share, in FY2023.
• Cash-flow generation weakened as inventory continued to build. Cash used in investing activities was $210.6 million, while financing activities provided $83.2 million, including proceeds from commercial paper.

Outlook, management commentary and risks

• Management cited increased global defense demand and plans by governments, particularly in Europe, to strengthen military capabilities. Since the October 2023 outbreak of the “Swords of Iron” war, IMOD demand increased materially; by March 15, 2024, the company reported more than $2 billion of IMOD awards since the war began, approximately $900 million of which was included in year-end backlog.
• The war also disrupted operations: reserve-duty mobilization affected approximately 15% of Israel-based employees at December 31, 2023, declining to approximately 7% by March 15, 2024. The company relocated some production lines, hired additional staff, increased inventories and rescheduled some customer deliveries. It said the full effect of the war could not be assessed.
• No quantified revenue or earnings guidance is provided in the supplied filing text. Management said existing cash, operating cash generation, credit lines and financing arrangements should provide sufficient resources for operational needs for at least the next fiscal year.
• Key exposures include fixed-price contract cost overruns and estimation risk, supply-chain constraints, workforce availability, customer delays or cancellations, export approvals and geopolitical developments. Inflation, NIS exchange-rate movements and higher interest rates may raise labor, input and borrowing costs. Government customer concentration and dependence on defense budgets are also material.
• Commitments include $3.856 billion of purchase commitments and approximately $2.50 billion of industrial-participation/offset obligations extending through 2033. Banks and financial institutions had issued $4.358 billion of guarantees, primarily for customer advances and performance obligations. Management said no significant legal proceedings were pending and that recorded claims accruals were not expected to result in a material adverse effect.
• The annual financial statements received an unqualified audit opinion. The auditor identified revenue recognition, defined-benefit pension obligations and ESA goodwill impairment testing as critical audit matters. Management and the auditor reported effective internal control over financial reporting as of year-end.

Important facts for investors to verify

• Review the audited statements and notes for debt maturities, variable-rate exposure, guarantee terms and the availability and conditions of credit facilities.
• Track inventory, contract assets, receivable collections and operating cash flow against revenue growth; verify whether backlog converts to revenue on schedule and without cancellations or adverse repricing.
• Assess the status and further costs of the subsidiary closure and discontinued project, and whether contract estimates-at-completion or loss provisions require additional revisions.
• Monitor the war’s effects on employee availability, production capacity, supply chains, deliveries and costs, alongside the timing and profitability of additional IMOD orders.
• Evaluate segment profitability—especially ESA—and the sustainability of 2023 improvements in Land and ISTAR and EW, excluding unusual items and comparing GAAP results with management’s non-GAAP measures.